Key result
Flavonoids act as potential antiviral candidates against Enterovirus A71 by inhibiting viral growth at the molecular level.
Why the study?
No clinically approved antiviral treatment is available for children suffering from hand, foot and mouth disease caused by Enterovirus A71.
Flavonoids represent a potential natural source of antiviral agents against Enterovirus A71, for which no clinically approved antiviral treatment currently exists.
Answers are grounded in this paper and cite their sources.
Should not yet change EV-A71 management; hypothesis-generating for flavonoid antivirals in prospective trials.
Flavonoids are natural biomolecules that are known to be effective antivirals. These biomolecules can act at different stages of viral infection, particularly at the molecular level to inhibit viral growth. Enterovirus A71 (EV-A71), a non-enveloped RNA virus, is one of the causative agents of hand, foot and mouth disease (HFMD), which is prevalent in Asia. Despite much effort, no clinically approved antiviral treatment is available for children suffering from HFMD. Flavonoids from plants serve as a vast reservoir of therapeutically active constituents that have been explored as potential antiviral candidates against RNA and DNA viruses. Here, we reviewed flavonoids as evidence-based natural sources of antivirals against non-picornaviruses and picornaviruses. The detailed molecular mechanisms involved in the inhibition of EV-A71 infections are discussed.
No takes yet. Share an insight, caveat, or question.
Lalani et al. (2020) conducted a review in Enterovirus A71 (EV-A71) infection / Hand, foot and mouth disease (HFMD). Flavonoids was evaluated. Flavonoids act as potential antiviral candidates against Enterovirus A71 by inhibiting viral growth at the molecular level.
Synapse has enriched 10 related papers. Consider them for comparative context: